Device Trauma & Extremities

Aequalis Perform Reversed

Payments companies reported to CMS as associated with Aequalis Perform Reversed. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.6Massociated payments (2023-2025)
1,930clinicians with associated payments
1company reporting

By year

2023 $592K
2024 $895K
2025 $1.1M

Payments reported as associated with Aequalis Perform Reversed, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $2.2M
Sports Medicine (Orthopaedic Surgery) $280K
Adult Reconstructive Orthopaedic Surgery $66K
Hand Surgery $26K
Physician Assistant $9,795
Surgical $2,374

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aequalis Perform Reversed

These are the largest totals companies reported as associated with Aequalis Perform Reversed. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jay Keener Saint Louis, MO Orthopaedic Surgery $671,261.58
Robert Tashjian Salt Lake City, UT Orthopaedic Surgery $586,545.52
Mark Mighell Temple Terrace, FL Orthopaedic Surgery $116,640.54
Benjamin Service Orlando, FL Orthopaedic Surgery $61,914.83
Armodios Hatzidakis Denver, CO Adult Reconstructive Orthopaedic Surgery $61,694.58
Dane Salazar Maywood, IL Orthopaedic Surgery $50,196.53
Michael Amini Willow Grove, PA Orthopaedic Surgery $48,093.64
Julie Bishop Columbus, OH Sports Medicine (Orthopaedic Surgery) $47,591.08
Vahid Entezari Philadelphia, PA Orthopaedic Surgery $45,063.49
Alexander Aleem Saint Louis, MO Orthopaedic Surgery $37,069.25

Prescribed Aequalis Perform Reversed?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.